Monitor for potential share price pressure due to near-term dilution; assess whether the capital raise extends the company's runway meaningfully into key clinical milestones.
Price Chart
Executive Summary
MAIA Biotechnology closed an underwritten public offering of 20 million shares at $1.50 per share, raising $30 million in gross proceeds. The company may raise an additional $4.5 million if underwriters exercise their 30-day option to purchase 3 million more shares. Proceeds will fund clinical trials and general corporate purposes.
Key Financial Metrics
Key Facts
- MAIA raised $30 million in gross proceeds through the sale of 20 million shares at $1.50 per share.
- Underwriters have a 30-day option to purchase up to an additional 3 million shares.
- Financing included participation from healthcare-dedicated investors and existing shareholders.
- Net proceeds will be used for clinical trials, working capital, and general corporate purposes.
- Offering was conducted under a shelf registration (Form S-3) declared effective in August 2023.
Financial Impact
$30 million gross proceeds, with potential for $4.5 million more; significant dilution expected due to large share issuance
Risk Factors
- Significant equity dilution for existing shareholders given the large number of new shares issued.
- No guarantee that clinical programs will advance successfully despite additional funding.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3249706 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 7, 2026 20d ago | EFFECT | $1.18 | awaiting T+60 | — | $1.11 (+5.93%) |
Oct 6, 2026 20d ago | 8-K | $1.19 | awaiting T+60 | — | $1.11 (−6.72%) |
Sep 25, 2026 4w ago | S-3 | $1.18 | awaiting T+60 | — | $1.11 (+5.93%) |
Sep 16, 2026 5w ago | Press Release | $1.40 | awaiting T+60 | — | $1.11 (−20.71%) |
Sep 15, 2026 5w ago | Press Release | $1.34 | awaiting T+60 | — | $1.11 (−17.16%) |
Sep 15, 2026 5w ago | Insider Cluster | $1.34 | awaiting T+60 | — | $1.11 (−17.16%) |
Jun 3, 2026 20w ago | Press Release | $1.43 $1.38 | ▼ −3.50% | ▼ −6.00% | $1.11 (−22.38%) |
Jun 2, 2026 20w ago | Insider Cluster | $1.35 $1.39 | ▲ +2.96% | ▲ +1.85% | $1.11 (−17.78%) |
May 19, 2026 22w ago | DEFA14A | $1.23 $1.34 | ▲ +8.94% | ▲ +2.65% | $1.11 (−9.76%) |
May 14, 2026 23w ago | 8-K | $1.26 $1.38 | ▲ +9.52% | ▲ +5.01% | $1.11 (−11.90%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers